Page last updated: 2024-09-05

sb 203580 and olmesartan

sb 203580 has been researched along with olmesartan in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(olmesartan)
Trials
(olmesartan)
Recent Studies (post-2010) (olmesartan)
3,48941,137841185554

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, S; Kyotani, Y; Nagayama, K; Ozawa, K; Yoshizumi, M; Zhao, J1

Other Studies

1 other study(ies) available for sb 203580 and olmesartan

ArticleYear
Olmesartan inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch through the inhibition of the c-Jun N-terminal kinase and p38 signaling pathways.
    Journal of pharmacological sciences, 2015, Volume: 127, Issue:1

    Topics: Animals; Anthracenes; Cell Death; Cells, Cultured; Enzyme Inhibitors; Imidazoles; JNK Mitogen-Activated Protein Kinases; Male; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats; Signal Transduction; Stress, Mechanical; Tetrazoles

2015